Harkirat Singh

Harkirat Singh practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Harkirat Singh's NPI, 1245528777, was assigned on July 18, 2011. Harkirat Singh holds Pennsylvania license MD460188.

Harkirat Singh's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Harkirat Singh's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Harkirat Singh is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Harkirat Singh to 5 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Harkirat Singh practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Harkirat Singh's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Harkirat Singh is licensed in Pennsylvania.

CMS data shows 421 Medicare services from Harkirat Singh across 15 procedure codes in 2024, for 216 Medicare patients. Medicare paid $45,254 for them.

CMS counts 216 Medicare patients who saw Harkirat Singh in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Harkirat Singh's median patient age at 71, with 47% women.

In 2024, Harkirat Singh wrote 380 Medicare Part D claims for 158 patients. 80% of them were for generic drugs. CMS names the drug for 263 of them, across 6 drugs with 11 or more claims each, at $124,836 in total drug cost. In 2023, CMS named 178 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Harkirat Singh for performance year 2024, reported as part of a group. Harkirat Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Harkirat Singh as offering telehealth. CMS counts 260 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Harkirat Singh, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 28 papers to Harkirat Singh, published from 2013 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Pancreatic Neoplasms, Endosonography and Drainage. Harkirat Singh has published most often in Clin Gastroenterol Hepatol. Harkirat Singh's most frequent co-authors are Amer H. Zureikat, MD, Rohit R. Das, MD, MPH and Alessandro Paniccia.

Dmand AI links Harkirat Singh to 1 clinical trial. Conditions studied include Pancreatitis and Pancreatic Diseases.

CMS Open Payments shows 29 general payments to Harkirat Singh from 4 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 76% of the total. Boston Scientific Corporation paid the most, $3,065.